Top

Reactions Weekly

Published in:

01-01-2023 | Pneumonia | Case report

Dexamethasone/favipiravir

Lack of efficacy following off-label use: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Kohara J, et al. Successful lung-protective ventilatory management during the VV-ECMO in a severe COVID-19 pneumonia patient with extensive pneumomediastinum and subcutaneous emphysema: a case report. JA Clinical Reports 8: 12, No. 1, 2022. Available from: URL: http://doi.org/10.1186/s40981-022-00505-8

Title: Dexamethasone/favipiravir
Lack of efficacy following off-label use: case report
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Pneumonia
COVID-19
ECMO
ECMO
Dexamethasone
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-30650-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Dexamethasone/favipiravir

Lack of efficacy following off-label use: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Aspirin/enoxaparin sodium/rivaroxaban

Codeine/lansoprazole/paracetamol

Tozinameran

Cytarabine/daunorubicin/midostaurin

Tacrolimus

Escitalopram/lorazepam/mirtazapine